|
Market Closed -
Euronext Paris
18:55:00 13/10/2026 +03
|
Pre-market 08:13:34 | |||
| 0.4660 EUR | +0.98% |
|
0.4680 | +0.43% |
| 09-08 | EARNINGS AND TRADING: Acuity eyes 'breakeven' as loss narrows | AN |
| 09-08 | Novacyt S.A. Launches IVDR-Certified Yourgene Insight DPYD Assay | CI |
| Market Cap | 33.79M 37.82M 31.49M 28.55M 53.73M 3.59B 54.15M 377M 148M 1.87B 142M 139M 5.99B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 35.74M 40.01M 33.31M 30.2M 56.84M 3.8B 57.29M 399M 156M 1.98B 150M 147M 6.34B | EV / Sales 2026 * |
1.17x | EV / Sales 2027 * | 1.11x |
| Free-Float |
99.83% | Yield 2026 * |
-
| Yield 2027 * | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALNOV | Real-time | |
London S.E.
| NCYT | Delayed | |
|
CBOE
| NCYT | Real-time | |
|
OTC Markets
| NVYTF | Delayed | |
|
Deutsche Boerse AG
| NYZ | Delayed | |
|
Börse Stuttgart
| NYZ | Delayed | |
|
Tradegate
| NYZ | Real-time | |
|
Boerse Muenchen
| NYZ | Real-time | |
|
CBOE
| NCYT | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Novacyt
| 09-30 | Novacyt : Interim Accounts June 2026 (EN) | PU |
| 09-30 | Novacyt : Rapport DActivité Semestriel 2026 (EN) | PU |
| 04-30 | Novacyt : 2025 Management Report | PU |
| 04-30 | Novacyt : 2025 Group Consolidated Accounts | PU |
| 22/10/25 | Novacyt : NCYT Re-launch Investor Film | PU |
| 1 day | +0.98% | ||
| 1 week | -11.24% | ||
| Current month | -5.86% | ||
| 1 month | -7.91% | ||
| 3 months | +13.80% | ||
| 6 months | +24.27% | ||
| Current year | +19.18% |
| 1 week | 0.46 |  | 0.5 |
| 1 month | 0.44 | | 0.54 |
| Current year | 0.29 | | 1.04 |
| 1 year | 0.29 | | 1.04 |
| 3 years | 0.29 | | 1.59 |
| 5 years | 0.29 | | 5.89 |
| 10 years | 0.06 | | 13.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lyn Rees
CEO | Chief Executive Officer | 53 | 01/05/2024 |
Steven Gibson
DFI | Director of Finance/CFO | 44 | 01/01/2020 |
Peter Coyne
COO | Chief Operating Officer | - | 01/11/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 03/07/2006 | |
Juliet Thompson
BRD | Director/Board Member | 60 | 27/06/2017 |
Steven Gibson
BRD | Director/Board Member | 44 | 02/01/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/30/26 A | Buy | Chief Executive Officer | 1,792 | 0.0025% | ||
| 3/30/26 A | Buy | Chairman | 15,228 | 0.0216% | ||
| 3/30/26 A | Buy | Chairman | 56,732 | 0.0803% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | -11.24% | -2.92% | -21.08% | 37.82M | |
| -0.32% | -5.97% | +57.78% | +74.48% | 70.44B | |
| -1.99% | -13.92% | +3.01% | +51.60% | 50.31B | |
| -1.32% | -1.70% | +6.99% | +35.47% | 47.51B | |
| -0.58% | +0.27% | +27.93% | +30.76% | 42.91B | |
| -2.84% | -5.72% | +286.54% | +530.02% | 40.39B | |
| -0.38% | -3.78% | +6.74% | +95.25% | 39.69B | |
| -0.39% | -1.48% | +10.41% | +43.19% | 30.59B | |
| -1.07% | -10.58% | +46.28% | +3.47% | 26.8B | |
| -7.13% | -7.02% | -12.99% | -14.07% | 22.36B | |
| Average | -1.50% | -6.20% | +42.98% | +82.91% | 37.1B | |
| Weighted average by Cap. | -1.46% | -5.61% | +50.83% | +100.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.52M 34.17M 28.45M 25.8M 48.54M 3.24B 48.93M 341M 133M 1.69B 128M 126M 5.41B | 34.86M 39.02M 32.49M 29.46M 55.44M 3.7B 55.88M 389M 152M 1.93B 147M 143M 6.18B |
| Net income | - | - |
| Net Debt | 1.96M 2.19M 1.82M 1.65M 3.11M 208M 3.14M 21.84M 8.55M 108M 8.22M 8.04M 347M | 4.84M 5.42M 4.51M 4.09M 7.7M 515M 7.76M 54.07M 21.16M 268M 20.36M 19.91M 859M |
Employees
228
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/10/26 | €0.4660 | +0.98% | 98,848 |
| 12/10/26 | €0.4615 | -0.75% | 75,825 |
| 09/10/26 | €0.4650 | -1.06% | 160,965 |
| 08/10/26 | €0.4700 | -4.37% | 361,717 |
| 07/10/26 | €0.4915 | -6.38% | 228,305 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALNOV Stock
Select your edition
All financial news and data tailored to specific country editions
